Toggle light / dark theme

A breakthrough in understanding how the quasi-particles known as magnetic monopoles behave could lead to the development of new technologies to replace electric charges.

Researchers at the University of Kent applied a combination of quantum and classic physics to investigate how magnetic atoms interact with each other to form composite objects known as ‘magnetic monopoles’.

Basing the study on materials known as Spin Ices, the team showed how the ‘hop’ of a monopole from one site in the crystal lattice of Spin Ice to the next can be achieved by flipping the direction of a single magnetic atom.

Check out new gameplay for XCOM 2 featured at E3 2015.

Visit all of our channels:
Features & Reviews — https://www.youtube.com/GameSpot
Gameplay & Guides — https://www.youtube.com/GameSpotGameplay
Trailers — https://www.youtube.com/GameSpotTrailers
Mobile Gaming — https://www.youtube.com/GameSpotMobile

Like — http://www.facebook.com/GameSpot
Follow — http://www.twitter.com/GameSpot
Stream Live — http://twitch.tv/GameSpot

http://www.gamespot.com

Amazon’s controversial facial recognition technology, called Rekognition, has a new skill. It can now spot fear. The company says it recently launched updates to Rekognition’s facial analysis features, including improved age estimation and the addition of fear to its emotion detection.

“We have improved accuracy for emotion detection (for all 7 emotions: ‘Happy,’ ‘Sad,’ ‘Angry,’ ‘Surprised,’ ‘Disgusted,’ ‘Calm’ and ‘Confused’) and added a new emotion: ‘Fear,’” according to an update from Amazon on Monday. “Lastly, we have improved age range estimation accuracy; you also get narrower age ranges across most age groups.”

In the future, we may have to deal with biological weapons that target specific groups of people, passing over everyone else.

That’s according to a new report out of Cambridge University’s Centre for the Study of Existential Risk reviewed by The Telegraph. In it, the Cambridge researchers argue that world governments have failed to prepare for futuristic weapons based on advanced technology like artificial intelligence and genetic manipulation — or even a killer pathogen designed to kill only people of a particular race.

Today [August 13] the US National Academy of Sciences is hosting the first meeting of the International Commission on the Clinical Use of Human Germline Genome Editing in Washington, to discuss controversial applications of CRISPR to human eggs, sperm, or fertilized ova, in the wake of Chinese researcher He Jiankui announcing the birth of CRISPR twins after a similar meeting in 2017 (See Do China’s controversial CRISPR babies illustrate the need for an undo button?)

Although only one clinical trial is up-and-running for CRISPR to treat body cells, with an initial patient making the media rounds just last week to discuss her cells doctored to counter sickle cell disease, many other applications are in preclinical testing — animal models and human cells and organoids. And they’re not restricted to rare diseases.

Imagine a single injection that quells the inflammation behind lower back pain — perhaps forever. CRISPR may make that possible by dampening the immune system’s cytokine signals, according to a report in the July issue of Human Gene Therapy.